LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 50 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,768,000 | -10.6% | 10,722,000 | -10.4% | 0.00% | 0.0% |
| Q3 2021 | $12,046,000 | -17.0% | 11,972,000 | -18.4% | 0.00% | 0.0% |
| Q2 2021 | $14,517,000 | +19.1% | 14,672,000 | +24.6% | 0.00% | 0.0% |
| Q1 2021 | $12,186,000 | +0.1% | 11,772,000 | -8.2% | 0.00% | 0.0% |
| Q4 2020 | $12,169,000 | +36.1% | 12,825,000 | +30.5% | 0.00% | 0.0% |
| Q3 2020 | $8,940,000 | -22.4% | 9,825,000 | -25.7% | 0.00% | 0.0% |
| Q2 2020 | $11,518,000 | -33.9% | 13,225,000 | -37.0% | 0.00% | -50.0% |
| Q1 2020 | $17,428,000 | -16.6% | 21,000,000 | -13.0% | 0.00% | +100.0% |
| Q4 2019 | $20,905,000 | +13.9% | 24,150,000 | +9.8% | 0.00% | 0.0% |
| Q3 2019 | $18,357,000 | -7.5% | 22,000,000 | -4.5% | 0.00% | 0.0% |
| Q2 2019 | $19,845,000 | – | 23,025,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS LLC | 300,000 | $298,682 | 0.00% |